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ABSTRACT
N-Acetoxy-N-Acetyl-2-Aminofluorene BINDING
SITES (N 0X174 AND SV40
by
Marta L. Bascoy
Restriction enzyme inhibition and lambda exonuclease
studies indicate that carcinogen N-acetoxy-N-acetyl-2 amino-
fluorene (AAAF) binds to sequences on IX174 RF and SV40
plasmids DNA that are similar to the eight preferred binding
sites previously located on pBR 322.
Both DNAs were digested with enzyme Hinf I and
resultant fragments 32P end-labeled. Labeled fragments
were reacted with the carcinogen to give one to sixteen
bound moieties per DNA. Fragments were isolated and
restriccion enzyme and lambda exonuclease inhibition assays
were performed.
Inhibition detected occurred at selected sites and was
not specific for a certain enzyme or certain size of
recognition sequence.
Results of these assays allow mapping of the location
of high affinity binding sites of the carcinogen on both
DNAs.
All sites have common sequence elements: the presence
of either the sequence T(G/C)TT(G/C) or the sequence T(G/C)
CTT(G/C).
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1INTRODUCTION
The present research intends to locate carcinogen
N-acetoxy-N-acetyl-2-aminofluorene (AAAF) binding sites on
bacteriophage (X-174 and monkey tumor virus SV-40 DNAs,
using restriction enzyme inhibition and lambda exonuclease
inhibition studies. The carcinogen used for this study
was chosen because its structure is known (fig.1), it is
reasonably stable and there have been preliminary studies
done on how it attacks DNA. (Singer & Grunberger, 1983;
Evans et al, 1980; Grunberger & Weinstein, 1978; Hogan et
al, 1980; Santella et al, 1980; Hingerty & Broyde, 1983).
AAAF is an intercalative binder with DNA that binds
covalently to guanine bases (Krick & Westra,1979; Hemminki,
K.,1983; Beland et al,1980). It has been shown by unwinding
supercoiled circular DNA (Drinkwater,N., et al,1978) and
circular dichroism (Fuchs & Daune,1972) that the planar ring
of AAF stacks between the base pairs. Circular dichroism
suggested that the guanine is displaced outside of the helix
when carcinogen is inserted into it. Linear dichroism
suggested that the AAF chromophore sits 80* to the helical
axis (Fuchs R., et al, 1976).
Formaldehyde unwinding, which measures helix stability
showed that the adducts increase the rate of unwinding and
destabilize the helix (Fuch & Daune,1974).
It is also evident that the G residue displaced by AAF
in the double helix can not base pair with the C residue on
2N0- 
--
CH3
C-CH 3
O
Carcinogen N-Acetoxy-NAcetyl-2-Amino-Fluorene
FIGURE 1
3the complimentary strand. During the process of replication
or transcription no base pairing at this position can occur.
The structural change that results from the presence
of the adduct is described as an insertion-deletion model
(fig.2) (Fuchs, R., et al, 1976; Grunberberger & Weinstein,
1978). The first feature of this model is that the attach-
ment of the AAF residue to the 8 position of G is associated
with a glycosyl change in conformation from anti to syn
(Evans et al,1978; Leng et,1980). Evidence of this is observ
ed in a study of molecular models of AAF-G that indicated
severe steric hindrance between AAF and the deoxyribose of
the nucleoside unless G base is rotated about the glycosyl
bond.
The second major feature of this model is that there
is a stacking interaction between AAF and a base adjacent to
the substituted G residue (Nelson et al,1971; Santella et
al,1980; Leng et al,1980; Lipkowitz et al,1982; Hingerty &
Broyde,1982).
Thermal denaturation studies are in good agreement
with The Base Displacement Model since AAF modification
decreases the melting point temperature of DNA. For each 1%
of the modified bases there is an approximate 1.5 "C de-
crease in melting point. A marked decrease of the intrinsic
viscosity of the DNA supports the idea that AAF binding
causes localized regions of distortion (Fuchs, R.,1975).
Since attachment of AAF to residues requires rotation
of the base about the glycosyl bond and there is less
4+
AAF
G
FIGURE 2. Base Displacement Model
Schematic model in which G residue has been
displaced by AAF in the double helix.
5hindrance to the rotation of bases in single stranded DNA
than in double stranded one, it follows that single stranded
regions of nucleic acid are more susceptible to AAF
modification than double stranded ones. Regardless of the
specifics of the model it is clear that AAF binding distorts
it.
The interaction mechanism between a restriction endo-
nuclease enzyme and the specific DNA sequence is an initial
binding to non specific sites and locating and recognizing
the specific sites by random diffusion along the DNA helix,
in particular, results obtained with EcoRI enzyme suggest
that the average distance scanned by the random walk
mechanism is about 1000 b.p.per DNA binding event under the
conditions employed (Richter & Eigen,1974; Schranner,1978).
Restriction inhibition enzyme has been used to
specifically locate the structural sequence features on the
DNA. Type II restriction endonucleases are sequence specific
enzymes which cleave double stranded DNA. Their relative
structural simplicity has rendered them attractive for study
of sequence-specific protein DNA-interaction (Modrich &
Roberts,1982). Type II recognition sites vary from 4 to 6
base pairs in length corresponding to expected frequencies
of sequence of one per 256 pairs to one per 4096 base pairs
respectively (Roberts,R.J.,1976; Roberts,R.J.,1980). With
few exceptions these sequences exhibit twofold rotational
symmetry and sites of DNA strand are symmetrically disposed
relative to the twofold axis.
6It has been shown that drugs like cis-dichlorodiamine
platinum II, inhibit the activity of a specific enzyme, in
this case enzyme BamH I, blocking at the recognition
sequence, causing inhibition by preventing access to the DNA
by the enzyme. (Weinstein & Grunberger,1974; Coffman &
Gaubatz,1982).
Lambda exo is a DNA exonuclease which cleaves one base
at a time from the 5' end. It is highly processive and will
stop when it encounters a block or a nick within the double
helix or will slow down when a single stranded region is
encountered. The processive nature of lambda exonuclease may
be explained by the enzyme having two active sites (Thomas &
Olivera,1978). It is believed that the enzyme is inhibited
at nicks because it remains bound to the last base pair
before the nick. (Carter & Radding,1971).
It has been shown that an alteration in the DNA at the
recognition sequence of a restriction enzyme causes
inhibition of the restriction enzyme (Mallamaci,1988). Since
AAAF modification has been shown to cause DNA denaturation
about its binding site, any restriction endonuclease or
lambda-exonuclease which has a recognition sequence near the
AAAF binding site should also be inhibited.
By systematic digestion of both plasmids under study
at a large number of restriction sites throughout them, it
was possible to map their location. Sites that showed
inhibition toward fragments which contained bound AAF and
those sites not inhibited were located.
7For this purpose, the plasmids were divided into
fragments of sizes between 100 to 700 base pairs in the case
of OX 174 and fragments from 20 to 1800 base pairs long in
SV 40's. Hinf I, used to generate a pool of fragments, was
chosen because it does not show detectable inhibition in
the presence of bound AAF moieties. (Mallamaci,1988)
Isolated fragments were then attacked by various
restriction enzymes that preferably cut only once at
specific sites within each fragment. The reason to choose
enzymes that cut once is because after the second enzymatic
digestion, fragments should be large enough to isolate and
visualize. They were run on an electrophoresis gel, placed
on a piece of X-ray film and analized.
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MATERIALS
PLASMID: SV 40 and IX 174 RF plasmids used in
this study were obtained from Bethesda Research
Laboratories or International Biotechnologies
Incorporated.
ENZYMES: Restriction enzymes as well as lambda
exonuclease were obtained either from Bethesda
Research Laboratories or International Biotechnoloa
ies Incorporated. All enzymes were used in the
buffers provided by the manufacturer (see table of
enzymatic conditions in appendix 1).
CARCINOGEN: The N-acetoxy-N-acetyl-2-amino-
fluorene used in the present research was prepared
by acetylation of the hydroxy-AAF with acetic anhy-
dride in pyridine and purified on an alumina column
with ethyl acetate.
METHODS
PREPARATION OF DOUBLE-END 32P LABELED HINF I
FRAGMENTS: For SV 40 DNA, 10 ug of SV 40 DNA was
9digested in a volume of 20 ul with 2 units of Hinf
I restriction endonuclease in reactant buffer #2
for 2 hours at 37 'C.
The restriction fragments were labeled by the
addition of 3 2PdATP, along with 2 ul of reactant
buffer #2, 8 ul of water and Klenow fragment. The
mixture was incubated for 20 minutes at room
temperature.
Fragments were precipitated by the addition of
2 volumes of 95% ethanol followed by an incubation
of 15 minutes at -70 °C in a dry ice bath. The DNA
was pelleted by centrifugation at 13000 rpm, washed
with 70% ethanol, and vacuum dried.
The same procedure was used for #X174 using 20
uL of DNA, 2uL of the enzyme (Hinf I) and 2 uL of
Reactant #2.
REACTION OF LABELED FRAGMENTS WITH ACETOXY-
AAF:The fragments obtained above were resuspended
in TE buffer (0.01 M tris, 0.001 M EDTA, ph 8.0)
and divided into equal portions. To these samples
were added increasing amounts of acetoxy-AAF as
appropriate to give the desired amounts of bound
carcinogen moieties per DNA.
ISOLATION OF FRAGMENTS: After reaction with
AAAF samples were electrophoresed on 6% polyacryla-
10
mide. For this purpose 6% polyacrylamide gel and
stock solutions were prepared according to appendix
2. The procedure followed for the 6% polyacrylamide
electrophoresis is described in appendix 3.
When the gel was finished, bands were visualiz
ed by staining the gel with ethidium bromide (0.1
g/ml) and transilluminated with a short wave U.V.
light box. DNA bands were excised and gel slices
soaked for 48 hours in 0.5 ammonium acetate
(pH 7.9).
Fragments were removed from ammonium acetate
by precipitation with 95% ethanol followed by
incubation in a -70 0C dry ice/ethanol bath for 15
minutes and washed. The DNA was pelleted by centri-
fugation at 13000 rpm for 15 minutes and washed
with 70% ethanol. Finally the DNA pellets were
vacuum dried and stored at 4 'C.
At this point 5 sets of Hinf I digested SV 40
or (X 174RF fragments, each with a different amount
of bound AAAF,were available for inhibition essays.
REACTION OF HINF I FRAGMENTS SETS WITH RESTRIC
TION ENZYMES: The following procedure was used in
all assays wich involved an enzyme possessing only
one cleavage site within the test DNA fragment. To
each sample was added 4 uL of the restriction
enzyme being tested. The enzyme was allowed to
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incubate with DNA in its manufacturer's recommended
buffer (see appendix for list) for one hour in a 37
oC water bath. The enzyme reaction was determined
by freezing the samples.
Reacted samples were placed on a 6% polyacryl-
amide gel and electrophoresed at 300 V for two
hours. For a single marker for partial digestion
products,where necessary, 3 2 P labeled fX 174 or SV
40 DNA were also run.
Once the electrophoresis was finished, gel was
removed from the apparatus and wrapped in plastic
film. The gel was placed in the film holder and in
the dark a piece of X-ray film was placed directly
onto the gel.
After exposure of the film to the radioactive
gel for an appropiate amount of time, the film was
developed.
The film was removed from the holder and plac-
ed into a tray containing developer and agitated
for four minutes. Development was stopped by
washing the film in cold water for one minute. The
film was placed into a tray containing fixer and
agitated for four minutes. The developed film was
washed in cold water five minutes and then air
dried.
The bands were then identified and analyzed
qualitatively on the radiograms by visible observa-
12
tion. (This analysis are in the chapter of
Results).
LAMBDA EXONUCLEASE INHIBITION ASSAYS:
Digestion of the labeled fragment sets with lambda-
exonuclease was carried out in 67 mM glycine-KOH
(pH 9.4), 2.5 mM magnesium chloride at 37 °C. To
each sample 0.01 ug salmon sperm DNA was added
prior to digestion.
For each digestion 0.05 units of lambda-exonu-
clease per base pair was employed. Digestion time
was 30 minutes. The amount of exonuclease required
to digest non acetoxy-AAAF containing fragments was
determined experimentally. Digestion was stopped by
ethanol precipitation.
The dried precipitated fragments were taken up
into deionized formamide (containig 0.001% Xylene
cyanol cis trach's dye) and heated in boiling water
for one to two minutes to denature the DNA.
The fragments were electrophoresed in 8 M urea
gel on 8% polyacrylamide gels. (See Appendix 2).
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RESULTS
I. SV 40 DNA INHIBITION USING RESTRICTION ENZYMES
After obtaining double-end32P labeled Hinf I
fragments, the general design of these inhibition
assays was to isolate restriction enzyme activity
within a fragment.
The gels were interpreted qualitatively as
follows: Figure 3 shows any set Hinf I fragment, cut
once by a restriction enzyme. The set of fragments has
increasing amounts of carcinogen, starting with no
carcinogen concentration up to 16 moieties of AAAF per
DNA molecule.
If the action of the restriction enzyme is
inhibited by the carcinogen, what is observed on the
gel is: (fig.4). The intensity of the band, uncut
fragment A + B with no carcinogen is almost
imperceptible because in this case the restriction
enzyme was not inhibited and most of the fragment has
been split in two sub-fragments A and B. When the
carcinogen reacts with DNA, the action of the enzyme
starts to be inhibited, so the fragment cannot be cut.
Therefore the intensity of the bands is observed to
increase with the increasing amount of carcinogen.
Since the restriction enzyme cuts the fragment
into sub-fragments A and B; then when the carcinogen is
14
DOUBLE END LABELED
(32 P)
* AIB*
A
SITE OF ENZYME CLEAVAGE
- HINF I FRAGMENT
SUBFRAGMENT A
SUBFRAGMENT B
FIGURE 3
Schematic reaction of Double-end 32P labeled
Hinf I fragment.
The Hinf I fragment is divided into two sub-
fragments A and B when the enzyme cuts it.
1 2 3 4
A+ B
- -A
B -- * _...-
FIGURE 4
Qualitative interpretation of gels when
Hinf I fragment is cut by a restriction
enzyme.
A+B is the uncut fragment.
Numbers represent a proportional amount
of carcinogen.
Lines represent band intensity.
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not present, the band of any of these sub-fragments is
intense, but the intensity gradually disappear with
higher concentration of carcinogen.
If a restriction enzyme not inhibited by the
carcinogen is used, (fig. 5) bands of equal intensity
are observed because action of carcinogen does not
inhibit the restriction enzyme.
Figure 6 shows when a enzyme cuts any set of Hinf
I fragment more than once (twice in this case)
generating sub-fragments A, B and C and inhibition
occurs in A. The set of this fragment is attacked by
increasing amounts of carcinogen concentration up to 16
moieties of AAAF/DNA.
For uncut fragment A+B+C (fig. 6), the intensity
of the band is almost imperceptible (when no AAAF is
added), because the enzyme tends to cut the fragment.
When the carcinogen reacts with DNA, the action of the
enzyme is inhibited as the concentration of the
carcinogen increases.
For sub-fragments A + B, with no carcinogen, no
bands appear on the gel, because enzyme has not been
inhibited and it cuts twice, and sub-fragment B which
is not labeled is impossible to see. With increasing
concentration of carcinogen a more intense band is
seen.
For sub-fragment A, when no carcinogen is present,
1 2 3 4
A
-*-------
FIGURE 5
Qualitative internretation o gels Uhen
Hinf I fragment is cut once by the
restrIction enzyrci t- tis in hbite
by the carcinoaen.
1 2 3 4
A+ B+ C ------ ------- ------- -------
A + B . ------
A -------
C
FIGURE 6
Qualitative interpretation of gels when
Hinf I fragment is cut by the restriction
enzyme more than once.
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an intense band is observed because action of the
enzyme is not inhibited. Increasing the concentration
of the carcinogen causes the band become less intense
and finally to disappear. For sub-fragment C when no
carcinogen is present an intense band is observed, for
the same reason explained for fragment A, but in this
case the bands have almost the same intensity when
concentration of AAAF increases, because it was not
inhibited. For most of the analysis enzymes cutting
once were preferentially used.
To verify visual observations bands were cut from
gels, placed into vials and 32P counted using
Beckmann LS5000 scintillation counter.
The counts per minute obtained from the total of
both sub-fragments A and B and the uncut fragment (A+B)
were added to obtain a total CPM level for each bound
AAF sample. This total is proportional to the number of
DNA ends. To determine the fraction of fragment
digested, CPM of the sub-fragments A and B are added
and divided by the total CPM of the sample and
multiplied by 100.
% digested = A+B x 100
total
Where total = A+B+(A+B)
These data are plotted on a percent digested vs. hound
20
AAF graph.
Graphs yielding a zero slope indicates no apparent
inhibition while graphs with a negative slope indicate
the presence of enzyme inhibition. (Fig. 7 and 8)
Table 1 provides information about enzymes used
for inhibition enzymes on SV 40 DNA.
Once restriction inhibition enzymes assays as
described in Materials and Methods, reaction of the
Hinf I fragment set with restriction enzymes and
further qualitative analysis of the autoradiography,
it was possible to know which enzymes were inhibited by
the carcinogen and which were not. Results are reported
in table 2.
There was one restriction enzyme which possessed a
single site within the Hinf I 1847 parent fragment. The
EcoRV site at base 771 appeared not inhibited. One
restriction enzyme with 2 sites, the Hha I at base pair
346 which was not inhibited and 836 which was
inhibited. The Hinf I 1085 bp fragment has 3 enzymes
with one restriction site. The enzymatic activities of
Ava II site at base pair 2014 and Pst I site at base
pair 1993 were not inhibited. Same fragment was cut by
Hae III between 2261 ad 2801 bp, being first one
inhibited and the other not inhibited.
Two enzymes on fragment Hinf I 525 were checked.
Sau 96 I at base pair 3171 which was inhibited and Rsa
I at bp 3074 , non inhibited.
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PHIX1 7 4 INHIBITION
HHA 1 691
100
0 0 0
80
O
-- 60
Cl,
O 40
20
0
0 10 20
[AAAF]
FIGURE 7
Percentage Inhibition vs. AAAF bound
for digestion of Hinf I base pair
fragment of OX 174 RF with Hha I.
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PHIX1 74 INHIBITION
HHA I 159
100
900
80
0
Z 70
O .
~ 60
C'
W 50
O 40
30 -
20
10
O
O 1n 20
[AAAF]
FIGURE 8
Percentage Inhibition vs. AAAF bound
for digestion of Hinf I 1847 base
pair fragment of SV 40 with Hha I.
23
Table 1
Inhibition Assays for SV 40 DNA
Hinf I Parent Fragment
Fragment Restriction Enzyme Location
Size (1) Sites (2) Used (3) (4)
1847 5136-1740 Hha I 346,836
EcoRV 771
1085 1740-2825 Hae III 2261-2800
Ava II 2014
Pst I 1993
766 3611-4377 Dra I 3910
Mbo I 3776-4100
525 2849-3374 Sau 96 I 3172
Rsa I 3074-3227
543 4593-5136 Taq I 4740
Hae III 4864
Ava II 5119
Sau 96 I 5119
Mbo I 4770
237 3374-3611 Sau 96 I 3539
Rsa I 3578
Ava II 3539
109 4460-4569 Dde I 4500
83 4377-4460 Dde I 4388
(1) The numbers given are the sizes (in base pairs)
Hinf I digested SV 40 fragments.
(2) The fragment size is contained between these
two sites.
(3) Restriction enzyme used for inhibition assay.It
should cut within the range of restriction sites.
(4) Location of enzyme cleavage.
24
Table 2
SV 40 Inhibition
0-1K(2)1-2K 2-3K 3-4K 4-5K 5-6K
INHIBITED (1)
Dde I -- -- -- -- 4500 --
Hae III -- -- 2261 -- -- --
Hha I 836 -- -- -- -- --
Rsa I -- -- -- 3578 -- --
Sau 961 -- -- -- 3172 -- --
NON-INHIBITED
Ava II -- -- 2014 3539 -- 5119
Dde I -- -- -- -- 4388 --
Dra I -- -- -- 3910 -- --
Eco RV 771 -- -- -- -- --
Hae III -- -- 2801 -- 4864 --
Hha I 346 -- -- -- -- --
Mbo I -- -- -- 3716 4100 --
4770
Pst I -- 1993 -- -- -- --
Rsa I -- -- -- 3074 -- --
Sau 96 I -- -- -- 3539 -- 5119
Taq I -- -- -- -- 4740 --
25
For fragment Hinf I 543, five enzymes were used
Taq I, Hae III, Ava II, Sau 96 I and Mbo I with
enzymatic activities at 4740, 4864, 5119 (Ava II and
Sau 96 I) and 4770 bp respectively. All of them were
not inhibited. Sau 96 I, Rsa I and Ava II were the
enzymes with a single site within the Hinf I 237
fragment at 3539,3578 and 3539 bp respectively. First
and third one were not inhibited and 3578 bp was
inhibited.
Dde I base pair 4500 was the enzyme assayed to see
its enzymatic activity on the Hinf I fragment 109. It
was inhibited by the carcinogen. Finally the same
enzyme possessed only one site within the Hinf I
fragment 83 at bp 4388 which was not inhibited.
II. INHIBITION ASSAYS FOR (X 174 DNA USING RESTRICTION
ENZYMES.
The same procedure and analysis was followed for
this DNA as for SV 40 one.
Table 3 summarizes the enzymes used for inhibition
assays on OX 174 DNA.
Qualitative analysis from autoradiography gave the
following results:
Four inhibition assays were performed on fragment
726 bp. Two of the 4 enzymes used have one site, Alu I
cuts at 447 bp and Sau 96 I at bp 979. Both of them
26
Table 3
Inhibition Assays for X 174 RF DNA
Hinf I Parent Fragment
Fragment Restriction Enzyme Location
Size Sites Used
726 393-1119 Alu I 447
Sau 96 I 979
Hha I 1023,691
Hae III 980
713 1185-1898 Hae III 1777
Rsa I 1433
Alu I 1454,1593
Hha I 1415
553 4149-4702 Hae III 4208-4489
Dde I 4253
Taq I 9181
500 2878-3378 Hha I 2980
Alu I 3166
Hae III 3130
Hpa II 3020
Rsa I 3189
427 4702-5129 Ava II 5043
Sau 96 I 5043
417 3732-4149 Taq I 4040
Alu I 3883,4137
413 2265-2678 Hha I 2366
311 5129-54 Alu I 5211
Taq I 5356
Pst I 1
249 2016-2265 Dde I 2014
Rsa I 2152
Tha I 2149
151 54-205 Hha I 159
Xho I 163
Alu I 171
118 1898-2016 Rsa I 1905
66 1119-1185 Hae III 1174
66 3378-3444 Alu I 3390
27
Table 4
PHI X 174 Inhibition
0-1K 1-2K 2-3K 3-4K 4-5K 5-6K
INHIBITED
Alu I 171 -- -- 3166 -- --
3312
Hae III -- 1777 -- 3130 4208 --
Hha I 159 1023 -- -- -- --
Hpa II -- -- -- 3020 -- --
Rsa I -- -- -- 3189 -- --
Taq I -- -- -- -- 4181 --
Xho I 163 -- -- -- -- --
NON-INHIBITED
Alu I 447 1454 -- 3390 -- 5211
1594
Ava II -- -- -- -- -- 5043
Dde I -- -- 2041 -- 4253 --
Hae III 980 1174 -- -- 4489 --
Hha I 691 1415 2366 -- -- --
2980
Pst I 1 -- -- -- -- --
Rsa I -- 1433 2152 -- -- --
1905
Sau 96 I 979 -- -- -- -- 5043
Tha I -- -- 2149 -- -- --
Taq I -- -- -- -- 4040 5356
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appeared to be inhibited. Although Hae III possessed 3
cleavage sites within this fragment (436, 670 and 980
base pairs) a label only on 980 end would enable
visualization in an autoradiogram. This site is not
inhibited by the carcinogen.
When Hha I cuts this fragment, it generates other
sub-fragments from which two of them were end-labeled
as described previously. One sub-fragment is from base
pair 150 to pb 691 and a second one from bp 1023 to bp
1146. Site 691 showed no inhibition and site 1023 was
inhibited.
Fragment 713 was checked by four different enzymes
Hae III, Rsa I, Alu I and Hha I.
The first two enzymes possessed one cleavage site
each on this fragment: Hae III activity showed
inhibition at 1777 bp but the activity of Rsa I was not
inhibited at bp 1433.
Alu I has 3 cleavage sites within this fragment,
at 1454, 1538 and 1593 but labeling at 1454 and 1593
ends would enable visualization on the radiograms. Both
sites showed non inhibition.
Hha I cuts 3 times within this fragment: at 1415,
1720 and 1865 bp; but only the one at 1415 was labeled
and the action of the enzyme was not inhibited.
On fragment 553, three inhibition assays were
performed. Enzyme Dde I had only one site at 4253 pb
which was not inhibited.
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Hae III cuts twice within this fragment at bp 4208
and 4489 respectively. First one was inhibited and
second one showed no inhibition.
Taq I cuts once at bp 4181 which showed inhibit-
ion. Five inhibition assays were tested on fragment
500 bp. Enzymes used were Hha I, Hae III, Rsa I, Alu I
and Hpa II. Hha I, Hae III and Rsa I have one site
within fragment. Hha I activity at 2980 bp was not
inhibited, Hae III activity at 3130 bp was inhibited
and Rsa I at 3189 bp, was inhibited.
Alu I cuts the fragment twice at 3166 and 3313 bp.
Both sites were inhibited.
Although Hpa II has two sites within this
fragment, 3020 bp and 3368 bp, only the first one was
end labeled which appeared inhibited by the action of
the carcinogen.
Ava II and Sau 96 I were the enzymes assayed on
fragment 427. Both of them have enzymatic activities
at 5043 bp site and were not inhibited.
Two inhibition assays were performed on 417 parent
Hinf I fragment.
Taq I only possessed one site on this fragment at
4040 bp which was non inhibited. Alu has three cleavage
sites within the same fragment, at 3841 bp, 3883 bp and
at 4137 bp. It was labeled on 3883 and 4137 ends. After
qualitative observation it was concluded that none of
these sites were inhibited.
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On fragment 413, just one inhibition assay was
done, using Hha I which cuts at 2366 bp. This site was
not inhibited.
Three restriction enzymes which possess a single
site within the Hinf I 311 bp parent fragment. The Alu
I site at bp 5211, the Taq I site at bp 5356 and the
Pst I at bp 1. They were not inhibited.
On fragment 249, three restriction enzymes were
observed, Dde I, Rsa I and Tha I, at bp 2041, bp 2152,
and at bp 2149 respectively. They were not inhibited
by the carcinogen.
Three restriction enzymes were used to test
inhibition on fragment 151, Hha I, Xho I and Alu I.
Hha I and Xho I, at bp 159 and at bp 163, respect-
ively, were inhibited. For Alu I, which cuts twice
within this fragment (at bp 162 and at bp 171), only
the 171 bp end was labeled for observation in the auto-
radiogram which showed inhibition.
For the Hinf I 118 parent fragment one inhibition
assay was done with the enzyme Rsa , which cuts once
within this fragment, at 1905 bp and was not inhibited
by the carcinogen.
Finally, there are 2 Hinf I parent fragments with
the same size of 66 bp. One has restriction sites
between 1119 bp and 1185 bp and the second one between
3378 bp 3378 and 3444 bp. For the first one, Hae III
was the enzyme checked which cuts at 1174 bp. For the
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second fragment, also one inhibition assay was done.
Alu I was the restruction enzyme chosen, that cuts this
fragment at 3390 bp. In both cases, activities of the
enzymes were inhibited.
III. LAMBDA EXONUCLEASE INHIBITION ASSAYS:
The results of the lambda-exo digests are
summarized in table 5. This information is obtained
from the sequencing gels. In all the autoradiograms
the size of the fragments was determined using the jX
marker. Analysis of the digest patterns are based on
the differences observed between the control and
experimental lanes. By comparing the lambda exo lanes
to the marker and counting down from the top of the
parent fragment, the size of the inhibition can be
determined.
Results from digestion of 4 fragments of SV 40
and 3 of 0X174 DNA are reported . The inhibition bands
for which locations are given are those appearing at
the lowest carcinogen concentration used, i.e., 1-3
carcinogen bound/DNA molecule. At higher concentrations
additional bands appeared in the vecinities of the
given bands.
Observing table 5 on fragment 525 (SV 40 DNA),
lambda exonuclease was inhibited between 3079 and 3089
bp. When restriction enzymes were analyzed on the same
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Table 5
Carcinogen Induced Lambda Exonuclease Inhibition
Fragment (1) Fragment Location of
Location (2) Inhibition (3)
SV 40
Hinf I 525 2849-3374 3079-3089
" 237 3374-3611 3554,3574
766 3611-4377 None
109 4460-4569 4489,4500
$X 174
Hinf I 151 54-205 144-150,170
" 249 2016-2265 None
311 5129-54 None
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fragment, inhibition of restriction enzyme Sau 96 I
around that region also was observed. (3172 bp).
On Hinf I fragment 237 the exonuclease was
inhibited at 3554,3574 bp. Restriction enzyme Rsa I at
3578 bp also showed inhibition.
When fragment 766 was examined, no inhibition was
observed, which agrees with the studies of restriction
enzymes. None of them (Dra I or Mbo I) were inhibited.
On fragment 109, lambda exonuclease presented
inhibition at 4489,4500 bp. Action of the restriction
enzyme Dde I over the same fragment at 4500 bp. was
also inhibited. For $X 174 RF DNA, same analysis was
done.
On fragment 151, exonuclease is inhibited in the
region of 144-150 bp and 170 bp.
Restriction enzymes used to cleavage the same
fragment: Hha I, Xho I and Alu I showed inhibition
around the region of 159,163 and 171 bp, respectively.
On the other side, on fragments 249 and 311,
neither lambda exonuclease nor the restriction enzymes
Rsa I, Tha I, Alu I and Pst I were inhibited.
The above analysis supports the idea about the
possibility of inhibition of any restriction enzyme
or lambda exonuclease as a consequence of the presence
of the carcinogen AAAF whose binding site is close to
the reconition site of the given enzyme, which was
suggested in the introduction of the present study.
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DISCUSSION
The purpose of these experiments was to identify and
localize any potential high affinity AAAF binding site
within SV 40 and X 174 DNAs plasmids. As discussed earlier,
the main concern was to detect any DNA alteration created by
the presence of the bound carcinogen. This alteration can
cause some form of inhibition to the restriction enzyme if
it is near its cleavage site.
The first region along the plasmid SV 40 in a clockwise
direction from the Bgl I, Sfi I site noted as base pair 0 up
to base pair 1740 found to contain an AAAF high affinity
binding sites. From the three sites tested, Hha I at bp 346,
Eco RV at pb 771 and Hha I at bp 836, only the last one was
inhibited. Since an AAF adduct is known to alter the helix
up to 20 bases away, a single adduct bound between bp 816
and 856 could be responsible for the inhibition observed in
this region but far enough away to cause inhibition at the
non inhibited sites.
The Hinf I 1085 bp fragment contains another high
affinity AAAF binding site. Within this fragment, Hae III
whit a restriction site at bp 2261 was inhibited. The sites
at bp 1993 for enzyme Pst I, bp 2014 for enzyme Ava II and
bp 2301 for Hae III were not affected by bound AAF so the
carcinogen bound between bp 2241 and 2281 bp could be
responsible for this inhibition. Two inhibition assays were
performed on the Hinf I fragment 525 bp extending from bp
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2849 to 3374. The one at bp 3172 showed evidence of
inhibition for the enzyme Sau 96 I, but the one at bp 3074
for Rsa I did not. So the possible location for carcinogen
binding site is between 3152 and 3192 bp. The next fragment
in a clockwise direction around the plasmid was the 237 bp
fragment, which extends from bp 3374 to 361. Inhibition was
observed within this fragment at the Rsa I site located at
bp 3578. However, sites at bp 3539 for Ava II and Sau 96 I
reflected no signs of inhibition. Bound carcinogen between
3558 bp and 3598 bp could be responsible for this
inhibition. Within the next fragment exists another high
affinity binding site. Assays on this 766 bp fragment at
restriction site 4500 bp for Dde I, observed enzyme
inhibition. The rest of the inhibition assays performed on
other fragments with enzymes Mbo I at 4100 and 4770 bp, Dde
I at 4388 bp, Taq I at 4740 bp, Hae III at 4864 bp and Ava
II and Sau 96 I, both at 5119 bp did not show inhibition.
For the X 174 RF DNA, the results of inhibition
studies are the following: In the first region along the
plasmid in a clockwise direction fom the bp 0 to bp 54, only
one site was tested, Pst I at bp 1 which did not show
inhibition. The Hinf I 151 bp fragment was checked by three
enzymes, Hha I at bp 159, Alu I at bp 171 and Xho I at 163.
All three enzymes were inhibited indicating that the
carcinogen bound in this region affected all three sites at
the same time. The next fragment was the Hinf I 726 bp,
which extends from 393 to 1119. Inhibition was observed in
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this fragment at the Hha I bp 1023. The sites at bp 447 for
Alu I, 979 for Sau 96 I, 691 for Hha I and 980 for Hae III
reflected no signs of inhibition. No inhibition was
observed within the fragment 66 bp, extending from 1119 to
1185 bp when Hae III was tested at bp 1174 site. Within the
713 bp fragment between 1185 and 1898 there exists another
high affinity binding site for Hae III at bp 1777. Three
other inhibition assays were performed on this fragment, at
bp 1433 for Rsa I, at bp 1454 and bp 1594 for Alu I. None of
these sites showed signs of inhibition. One inhibition
assay was performed on the Hinf I 118 bp fragment extending
from 1898 to 2016, which did not show inhibition at bp 1905
for Rsa I restriction enzyme. The next fragment in a clock-
wise direction around the plasmid was the 249 bp fragment
which extends from bp 2016 to bp 2265. No inhibition was
found at any of the sites checked, which were at bp 2041 for
Dde I and 2152 for Rsa I. For fragment Hinf I 413 bp only
one inhibition assay was done. No inhibition was observed at
the Hha I site located at bp 2366. Within the next region
the fragment 500 bp, five inhibition assays were peformed.
Only the one at site 2089 bp for Hha I did not show
inhibition. The rest of sites at bp 3166 for Alu I, 3130 for
Hae III, 3020 for Hpa II and 3189 for Rsa I were inhibited.
Within these high affinity binding sites of carcinogen,
there are three possible sites where the carcinogen could
affect. One covered the sites 3166 and 3189, a second was at
site 3020 and the last one was at 3130. Over the next
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fragment of 66 bp, extending from 3378 to 3444 only one
inhibition assay was done, bp 3390 for Alu I, which did not
show inhibition. One site of high affinity binding site of
carcinogen exists within the Hinf I 417 bp fragment. This
fragment goes from bp 3732 to bp 4149. It was located at bp
4137 for Alu I. No inhibition was observed for the same
enzyme at bp 3883 or for the Taq I site at 4040 bp. The
next region in the clockwise direction along the plasmid is
4702 bp. Three inhibition assays were performed on it,
activity of Hae III at bp 4208 and at bp 4489 and bp 4253
for Dde I were tested. Both assays for Hae III showed
inhibition while the site for Dde I did not. None of the
inhibition assays checked on fragment 427 bp between bp 4702
and 5129 showed inhibition. Those included sites at bp 5043
for Ava II and for Sau 96 I.
Based on the above analysis, tables 6 and 7 were
constructed; these are segments of sequence close to the
inhibition site.
From these segments of sequence for all the enzymes
inhibited on both DNAs, a common sequence was observed which
appears in the vicinities of the inhibition site. This
common sequence is underlined on each segment of sequence.
For SV 40 DNA, five sites of high affinity for binding
carcinogen were found, while seven were found on (X 174. It
is clear from the results summarized in tables 6 and 7 that
restriction enzyme inhibition does not occur randomly along
the plasmids.
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Table 6
Carcinogen Binding Sequences SV 40
*841 (2)
G T G T G A G C G C T G T T G C T A A G T G (1)
(3)
*2258
A T G A G C A G G G T G T T G G G C C C T T
*4499
A G A T G G C A T T T CT T C T G A G C A A
*3576
T T T T T A G G A A T G T T G T A C A C C A
*3088
T T T A A A T A A T C C T T G G C C C T A A
(1) Segment of total nucleotide SV 40 DNA sequence.
(2) *- Reference number to locate the common sequence.
(3) Underlined common seugence.
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Table 7
Carcinogen Binding Sequences X174RF
*154
A C C T A T C C T T G C G C A G C T C
*4095
C C C A A T G C T T G G C T T C C A T
*3337
G C T G A T G C T T C C T C T G C T G
*3036
G T G A G T G C T T G C T A C C G A T
*4213
A A G G C T G C T T C T G A C G T T C
*1054
T T C C C A T C T T G G C T T C C T T
*4173
T C A A G C T C T T G G A A G A G A T
*3174
A G G A C T T C T T G A A G G T A G G
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Table 8
Carcinogen Binding Sequences pBR 322
*962
G C T G G G C T A C G T C T T G C T G G C G T
*3040
G A G T T G G T A G C T C T T G A T C C G G C
*692
C C C A G T C A G C T C C T T C C G G T G G G
*2394
C T G C G C T C G G T C G T T C G G C T G C G
*3725
A G C G G T T A G C T C C T T C G G T C C T C
*2194
G C G T C A G C G G G T G T T G G C G G G T G
*2356
G C A T C A G G C G C T C T T C C G G T T C C
*1113
T C G C T C G C G G C T C T T A C C A G C C T
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On SV 40 DNA, four of the segments showed the common
sequence T(G/C)TTG and one was TCCTTG. For JX 174, five of
the segments showed the common sequence T(G/C)CTT(G/C) and
three .ire TCTTG.
Generalizing over the elements of these common
sequences, it was possible to assign a general common
sequence.
For four sites on SV 40 DNA and three on (X 174 DNA
T(G/C)TT(G/C)
For one site on SV 40 and five sites on 4X 174
T(G/C)CTT(G/C)
It should also be pointed out that the same enzyme
found inhibited at one site, should to be not inhibited at
other site. This suggests that the inhibition detected in
these assays was not specific for a certain enzyme.
In contrast with this, other researchers have found
that an alteration in the DNA at recognition sequence for a
specific enzyme causes inhibition in its activity (Vardimon,
L. and Rich, A.,1984). Agents like cis-dichlorodiamino-
platinum II block the enzyme BamH I at its recognition
sequence, causing inhibition by preventing access to the DNA
for the enzyme. (Weinstein, I.B., Grunberger, 1974;
Coffmann, G.L., Gaubatz, J.W.,1982). Additionally daunomycin
(Malcolm, A.D., Moffati, J.R.,1981) as well as anthramycin
(Sumner, W., Bennett, G.N. 1981) which are non-covalent DNA
binding agents cause specific restriction enzyme inhibition.
The size of the recognition sequence did not seem to be a
factor since enzyms with 5 base pairs all possess sites on
SV 40 and OX 174, where they were inhibited in the presence
of the carcinogen.
Experiments performed on pBR 322 (Mallamaci, M.A.,1988)
have shown that locations of observed lambda exonuclease as
well as restriction endonuclease inhibition are the same
than those on the DNAs examined in the present study.
Comparison of the sequences at the sites of inhibition
on pBR 322 indicate the presence of the same common sequence
elements on SV 40 and OX 174. (see table 8)
This fact is providing strong evidence that the
carcinogen AAAF targets for a family of specific DNA
sequences which are found on DNAs from a variety of sources.
There are two models describing the conformational
details of AAF-modified nucleic acids. The base displacement
model has the bound AAF moiety displacing the guanine (to
which is attached) from the helix. (Weinstein, I.B.,
Grunberger, D. 1974; Evans, F.E., Miller, D.W.,1980; Leng,
M.,Ptak, M.,Rio, P.,1980; Hingerty, B. and Broyde, S.,1982;
Sage, E. and Leng M.,1980). The insertion denaturation model
has the bound AAAF disrupting the helix by placement in a
groove of the DNA. (Fuchs, R. and Daune, M.1971,1972,1973,
1974,1975,1976; Box, H.C, Lilga, K.T. et al,1984).
Regardless of differences in structural detail, both
models invoke alterations in DNA structure resulting from
carcinogen binding.
Other researchers suggest that for certain sequences a
n3
Z- like DNA structure has been determined with the fluorene
ring residing on the outside of the helix.(Santella, R.,
Grunberger, D., Hingerty, B., and Broyde S.,1981; Standford
and Krugh, 1985; Fuchs, Schwartz, Daune,1983).
However, in either case the presence of the adduct
would present a blockage for the enzyme to overcome which
would result in enzyme inhibition.
It is clear that the complex sequence found within
every high affinity AAAF binding site strongly suggest the
binding is sequence specific.
The process by which an AAAF molecule goes to specific
sites is still unknown; however some aspects make the
sequence likely target for attack by the carcinogen : the
presence of adjacent "GC" bases preceeded by adjacent "TT"
bases and sometimes preceeded by a third "T" base. It has
been shown by Fuchs (1983), that the carcinogen binds
preferentially to a G adjacent to a C. Also the presence of
flanking thymines may help to ease denaturation because AT
base pair have a lower melting point than GC base pairs.
Other studies have proposed that AAAF binding sites
occur either in the middle or terminal regions of resistance
genes or within the origin of replication. (Mallamaci,M.A.,
1988) (see table 9 and figures 9 and 10) (Reddy,V.B.,
Thimmappaya, B., et al, 1978; Sanger, F.,Air,G.M., et al,
1978; Fiers W., Contreras, R., et al,1978; Sanger, F.,
Coulson, A.R., et al, 1978). Since none of these binding
sites occur within a non-coding region, that is suggesting
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that the processes of replication or transcription do not
take place in the presence of carcinogen.
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Table 9
Gene code for Site of Site of
struct.protein init.(bp) terminat.(bp)
SV 40 A 2220 3396
B 888 1698
C 3396 3908
D 3970 4493
E 4493 4963
F 5146 5224
G 512 888
H 1943 2220
I 1698 1943
J 261 512
K 4963 5146
L 3907 3944
M 3944 3970
OX 174 A 3973 123
B 5064 38
C 134 391
D 390 846
E 568 840
F 1001 2276
G 2387 2912
H 2923 3907
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PEPU CATION
FIGURE 9: SV 40 DNA
MAP FOR INHIBITION SITES AND GENES CODING
STRUCTURAL PROTEINS
Inner circle shows location of proteins and origin
of replication along the DNA in terms of base
pairs. Outer circle shows carcinogen sites location.
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FIGURE 10: OX 174 RF
MAP FOR INHIBITION SITES AND GENES CODING
STRUCTURAL PROTEINS
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CONCLUSIONS
As shown by the results of restriction enzyme inhibit-
ion and lambda exonuclease inhibition assays, these studies
allowed to map the locations of high affinity binding sites
of the carcinogen N-acetoxy-N-acetyl-2-aminofluorene (AAAF)
on the plasmids SV 40 and X 174 RF DNAs.
For both, enzymes types inhibition increased as bound
carcinogen concentration increased; this was basically
determined qualitatively and in some cases verified quant-
itatively.
Inhibition detected is not specific for a certain enzy-
me or certain size of recognition sequence.
The locations of observed lambda exonuclease inhibition
are the same, in all cases, as the locations of observed
restriction enzyme inhibition.
With the number of inhibition assays performed, it was
found eight sites on fX 174 and five on SV 40 of inhibition
of the enzymatic activity by the carcinogen.
All sites have common sequence elements. The presence
of either the sequence T(G/C)TT(G/C) or the sequence T(G/C)C
TT(G/C). It is also clear that inhibition enzyme occurred at
selected sites.
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Appendix 1
Restriction Endonucleases Used and
Their Enzymatic Conditions
Restriction Enzyme Reaction conditions
Alu I 37 'C- React #1
Ava II 37 C- React #2
Dde I 37C- React #2
Dra I 37°C- React #1
Eco RV 37 C- React #2
Hae III 37'C- React #2
Hha I 37°C- React #2
Hpa II 37*C- React #8
Mbo I 37*C- React #2
Pst I 37'C- React #2
Rsa I 37"C- React #1
Sau 96 I 37-C- React #11
Taq I 65cC- React #2
Tha I 60°C- React #1
Xho I 37*C- React #2
(Taken from Bethesda Research Laboratories catalogue and
reference guide)
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Appendix 2
6% Polyacrylamide gel
Reagents Volume (mL)
30% acrylamide 6
1oX TBE Buffer 3
Water 21
Ammonium persulfate
30% Acrylamide
Acrylamide 29 g
Bis 1 g
Complete to 100 mL with water
1oX TBE Buffer
Tris (basic) 121 g
Boric acid 55 g
EDTA 7.44 g
8M Urea gel in 8% acrylamide
Urea 14.4 g
10 TBE 3 mL
Acrylamide 8 mL
Water to 30 mL
Ammonium persulfate
Appendix 3
6% polyacrylamide electrophoresis
For pouring the gel, glass plates (2) were used. They
were washed with ethyl acetate to remove grease and set
aside to dry. The larger outer plate was laying on a bench
and two space bars were placed along the sides with vaseline
to help keeping the spacer bars in position during ne::t
steps. The inner plate was laying in position resting on the
space bars and four clamps were placed to compress and form
a seal between plates. Four mls from the total volume
solution of 30 mis of 6% polyacrylamide were taken and a
proportional amount of TEMED (30 ml of TEMED/100 ml of poly-
acrylamide) was added and mixed with the solution to help
polymerization. This solution was poured with a pasteur
pipette into the space between plates at the foot to make
the lower position of the gel. When acrylamide polymerized,
the rest of the gel (26 ml) was poured, previous addition of
TEMED filling to the top.
Inmediately an appropriate comb was inserted between
plates in such a way that the tops of the teeth were slight-
ly higher tan the top of the glass plate and being careful
not to allow air bubbles under the teeth. Acrylamide was
allowed to polymerize at room temperature for 20 minutes.
When polymerization was complete, Schlieren pattern appeared
just beneath the teeth.
Comb was removed and gel was attached to the
electrophoresis tank, leaving the inner plate against the
tank with bulldog clips. Then, reservoirs were filled with
the ten times diluted 1OX buffer, flushing out the wells.
Electrodes were connected to a power pack (positive out let
connected to the bottom reservoir) and gel was run for 30
minutes at 250 volts.
For addition of DNA samples, 10 ul of marker dye (bromo
phenol blue 0,1%) and they were loaded on patterns of 6%
polyacrylamide gel and electrophoresed for 2 to 3 hours.
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Abbreviations
AAAF....... Carcinogen N-acetoxy-N-acetyl-2-aminofluorene
DNA...... Deoxyribonucleic acid
G-.-.- -... Guanine base
C........ Cytosine base
bp....... Base pair(s)
ug....... Microgram
ul....... Microliter
rpm...... Revolutions per minute
TE buffer 0.01 M tris, 0.001 M EDTA, pH 8 buffer
U.V...... Ultraviolet
V........ Volts
mM....... Milimolar
CPM...... Counts per minute
EDTA..... Ethylendiaminotetraacetic acid
TBE...... Tris, boric acid, EDTA, buffer
TEMED.... N,N,N',N'-Tetramethylethylenediamine
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